Twenty patients presenting for submucous resection of the nasal septum under general anaesthesia were randomly allocated to four groups to receive either 1.0 ml 25% cocaine HCI in paraffin paste, 1.0 m125% cocaine HCI combined with 0.1% adrenaline in paraffin paste, 4.0 ml aqueous 4% cocaine HCI combined with 0.050/0 adrenaline or 4.0 ml aqueous 4% cocaine HCI on ribbon gauze applied to the nasal mucosa. Mean intraoperative blood loss was significantly decreased when the 25% cocaine 0.1% adrenaline combination in paraffin paste was used (11 (SD 8) ml, 60 (SD 30) ml, P<0.05, for adrenaline and plain paste respectively). Combination of adrenaline with cocaine in the aqueous formulation was not associated with a significant decrease in blood loss compared with aqueous cocaine alone (75 (SD 51), 96 (SD 66) ml respectively). Cocaine adrenaline paste and plain cocaine paste were associated with higher mean maximum cocaine blood concentrations (1.6 (SD 1.4), 2.0 (SD 1.5) JAg/ml respectively) when compared with aqueous cocaine adrenaline and aqueous cocaine alone (0.03 (SD 0.003), 0.5 (SD 0.3) JAg/ml respectively). Heart rate and blood pressure changes were similar in all four groups and cardiovascular toxicity was not observed. One ml of topical intranasal 25 % cocaine HCI with 0.1 % adrenaline in paraffin paste provided the best haemostasis for nasal septal surgery.
cocaine/adrenaline combinations. Delilkan 4 observed that when 2.0 ml of 5OJo aqueous cocaine combined with 1: 1000 adrenaline was applied topically to the nasal mucosa in patients under general anaesthesia, heart rate and systolic blood pressure increased, but operative blood loss was not reduced when compared with the same dose of plain aqueous cocaine. In contrast, Beaumont 5 observed less operative blood loss when 1.0 ml of 25% cocaine HCl combined with 1: 1000 adrenaline in paraffin paste was used compared with plain 25070 cocaine paste formulation.
The present study was designed to determine whether this reported improved haemostatic action due to adrenaline could be confirmed, and if so, whether the physical properties of the vehicle were a major factor. In addition, observations were made to detect any evidence of cardiovascular toxicity.
MATERIALS AND METHODS
Twenty healthy patients (ASA I or 11) presenting for submucous resection of the nasal septum (SMR) were studied. They were randomly divided into four groups of five patients. Only patients free of detectable cardiorespiratory disease were accepted. No patient was receiving any form of drug therapy likely to alter cardiovascular function. Each patient was allocated to receive one of the following formulations of cocaine to be applied topically to the nasal mucosa after induction of anaesthesia. All anaesthetics were administered by the same team (FL and 1 O'R) and all operations were performed by the same surgeon (DC).
Anaesthesia was induced with fentanyl 1.4 J..Ig/kg, thiopentone 5 mg/kg, and muscle relaxation was achieved with alcuronium 0.3 mg/kg. The patient was then intubated with a cuffed armoured latex endotracheal tube, a throat pack was inserted and the patient was positioned with 15 0 head-up tilt.
Blood pressure was measured before induction of anaesthesia and thereafter at fiveminute intervals by sphygmomanometry. An electrocardiograph was monitored by continuous chart recorder. Blood (1.0 ml) was taken for cocaine concentrations at ten-minute ·King's College Hospital formula with adrenaline acid tartrate substituted for suprarenal extract.
intervals from the time of commencement of cocaine application and for 90 minutes subsequently. Patients were ventilated with a circle system without C02 absorption, using fresh gas flows of 70 mllkg/min of nitrous oxide and oxygen in a ratio of 2: 1. Tidal volume was set at 10 mllkg and respiratory rate at 10 per minute to produce similar arterial carbon dioxide tensions in all patients, after the technique described by Gibb and Pollard. 6 Eight minutes after endotracheal intubation, one of the cocaine formulations was applied to the nasal mucosa. When the aqueous solution was used, all 30 inches of gauze was inserted. The study was blind only with respect to the adrenaline content of the formulations. Ten minutes later, residual cocaine from the nose was aspirated, and surgery commenced. At completion of surgery, the throat pack was removed, immersed in 500 ml of distilled water. Muscle relaxation was reversed with neostigmine 2.5 mg, atropine 1.2 mg, the patient was extubated and positioned with 30 0 head-up tilt when fully conscious. Operative blood loss was determined as the sum of that measured in the sucker bottle and that on the throat pack which was calculated as follows: blood that collected on the throat pack was eluted in 500 ml of water over two hours. The optical density (OD) of the eluted sample was read in triplicate at 700 mu in a Gilford 300 T-l spectrophotometer (Gilford Instrument Laboratories Inc., Ohio, ONI0 44079). Similarly, a second OD reading was obtained from 3.0 ml of the patient's blood diluted to 100 ml. Blood loss was then calculated by the following equation:
OD pack eluent 3 Blood loss =
x 500 x -ml OD diluted patient blood lOO This method was found to produce reliable results for standard volumes of 2-16 ml of blood pipetted onto throat pack gauze: r =0.995, intercept, 0.6 ml, slope 0.93.
At the completion of the operation the surgeon made an assessment of difficulty on a 4-point scale, rating from 4 = very difficult, to 1 = very easy.
Blood cocaine concentrations were measured with a nitrogen sensitive detector after several extractions by gas-liquid chromatography. Blood samples were collected in heparinised tubes containing 0.25 ml saturated sodium (Table 1) . Cocaine 2S070'with 0.1070 adrenaline in paraffin paste was the formulation that provided the last mean blood loss (11 (SD 8 ml), P<O.OS) ( Table 2 ).
The surgeon's rating of difficulty ranged from a modal score of 4 for the aqueous cocaine group, to a modal score of 2 for the cocaine paste with adrenaline group (Figure 1 )-There were no differences in heart rate ( Figure 2 ) and mean arterial pressure ( Figure 3 ) among any of the four groups. No cardiac arrhythmias were observed in any patient. Cocaine blood concentrations were much higher in patients who received either of the cocaine paste formulations (Figure 4) . Adrenaline significantly reduced the mean maximum blood level (Cmax) and area under the concentration time curve (AUC) in the aqueous cocaine formulation (P<O.OS) but not in the paste formulations (Table 4 ). 
DISCUSSION
The study was suspended at completion of 20 cases as the surgeon noticed some consistent differences in terms of difficulty and blood loss between the two paste groups (see Figure 1 ). It was considered unethical to proceed with the study until some preliminary statistical tests were made.
A non-parametric approach was used because the values for blood loss were not normally distributed. The Kruskal-Wallis oneway analysis of variance returned P< 0.05, and we concluded that the populations in the above four samples differed. By inspection the comparison of clinical importance which looked statistically significant was that between cocaine paste and cocaine paste with adrenaline. There was no overlap in the ranges of values between these two paste groups. The statistical significance of this can be tested by the Mann-Whitney U test, or equivalently by appealing to the hypergeometric distribution. The probability of obtaining such a discrepancy by chance is P= 11126. On this basis we do not believe the results for blood loss are compromised by the small numbers studied. Topical 25010 cocaine combined with 0.1 % adrenaline in paraffin paste was associated with the least blood loss of all four formulations studied. Our observation that haemostasis was improved when the two agents were combined in a paraffin vehicle but not in an aqueous vehicle corroborates the findings of earlier studies. 4 . 5 Beaumont 5 observed a reduction in mean blood loss from 90 ml to 10 ml when adrenaline was combined with cocaine in a paste formulation ( Table 3 ). Delilkan et al. 4 observed no difference in mean blood loss when 2.0 ml of 5% cocaine HCl were compared with 2.0 ml of 5010 cocaine HCl combined with 0.1 % adrenaline in an aqueous formulation.
With respect to blood loss, this study supports the results of both Beaumont 5 and Delilkan 4 indicating that a cocaine adrenaline combination has additive haemostatic effects when combined in a paraffin formulation but not in an aqueous formulation.
No differences in heart rate or blood pressure was observed between the adrenaline/cocaine and plain cocaine groups. This contrasts with Delilkan's4 observations of increased systolic blood pressure and heart rate when cocaine and adrenaline were combined but not with the high (200 mg) and low (100 mg) dose of aqueous cocaine alone.
No sympathomimetic or cardiotoxic effects were observed, but the numbers in this study are too small to conclude with confidence that the dose and formulation of cocaine, combined with patient selection and anaesthetic technique, resulted in avoidance of toxicity. However, in our institution, cocaine/ adrenaline paste is applied routinely with the above precautions and has not resulted in a toxic reaction.
Cocaine absorption across the nasal mucosa was not significantly reduced by the presence of adrenaline in the paste formulation but was reduced by the presence of adrenaline in the aqueous formulation (Table 4 ). We are unable to explain the anomaly of reduced cocaine absorption without reduced blood loss in the aqueous formulation since both effects should • P<0.05 (Hest) be related to the vasoconstrictor effects of adrenaline.
The lower cocaine blood levels associated with the aqueous formulations may have been due to the absorption of cocaine into the ribbon gauze, reducing the dose actually applied to the nasal mucosa.
The ribbon gauze method of topical application of aqueous cocaine/adrenaline was familiar to the surgeon (DC) so was adopted for the study. The authors were reluctant to apply the direct method of application as used in Delilkan's study because of the sympathomimetic effects observed.
The toxic blood level of cocaine in man is unknown. A peak plasma level of 1.82 /Ag/ml* was observed without toxicity after a 100 mg IV bolus of cocaine HCl was administered in an unanaesthetised patient. 7 This level is comparable to our mean maximum recorded blood level in anaesthetised patients of 2 /Ag/ml in the plain paste group. During nasal surgery without general anaesthesia,8 mean peak blood levels of 0.116 /Ag/ml were recorded, considerably lower than our observations. One toxic reaction was observed at a blood level of 0.35 /Ag/ml. In the absence of general anaesthesia endogenous catecholamines may have been raised due to anxiety in this case, and may have contributed to the toxic effect of cocaine observed at this relatively low blood level.
Nasal application of cocaine is considerably safer than other routes of administration 2 as the area under the concentration time curve is one-'Blood and plasma cocaine levels are not strictly comparable but the former would have higher equivalent value depending on haematocrit and partitioning of cocaine between plasma and red blood cells. sixth that of a similar IV dose. 9 Peak blood levels would therefore be less when equal doses of the drug are given intranasally, compared with intravenously. Blood levels are higher in surgical patients compared with volunteers, presumably due to increased absorption from the traumatised nasal mucosa. 8 One ml of 25070 cocaine combined with 0.1 % adrenaline in paraffin paste applied to the nasal mucosa provided the best haemostasis compared with cocaine paste alone or cocaine combined with adrenaline in aqueous formulation. We believe that the precautions adopted in the study and summarised below contributed to the fact that toxicity and sympathetic stimulation were not observed with the dose of cocaine adrenaline paste used (225 mg/0.9 mg respectively). Care should be taken to: 1. measure by volume to a limit of 1 ml per 70 kg the appropriate dose of cocaine/adrenaline paste; 2. apply the cocaine/adrenaline paste after the sympathetic effects of endotracheal intubation have passed; 3. aspirate any residual cocaine/adrenaline paste before commencement of surgery; 4. exclude its use in patients with cardiovascular disease; and 5. adopt an anaesthetic technique with controlled ventilation, narcotic supplementation and avoidance of volatile anaesthetic agents.
